Overview
Chiharu Iwahashi practices in Osaka, Japan. Iwahashi is rated as an Experienced expert by MediFind in the treatment of Mantle Cell Lymphoma (MCL). Their top areas of expertise are Retinal Detachment, Retinopathy of Prematurity, Uveitis, Vogt-Koyanagi-Harada Disease, and Vitrectomy.
Their clinical research consists of co-authoring 34 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 1 article in the study of Mantle Cell Lymphoma (MCL).
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Central Serous Chorioretinopathy
- Retinal DetachmentIwahashi isAdvanced. Learn about Retinal Detachment.
- Retinopathy of PrematurityIwahashi isAdvanced. Learn about Retinopathy of Prematurity.
- UveitisIwahashi isAdvanced. Learn about Uveitis.
- VitrectomyIwahashi isAdvanced. Learn about Vitrectomy.
- Vogt-Koyanagi-Harada DiseaseIwahashi isAdvanced. Learn about Vogt-Koyanagi-Harada Disease.
- Experienced
- Age-Related Macular Degeneration (ARMD)
- EpiscleritisIwahashi isExperienced. Learn about Episcleritis.
- Familial Exudative Vitreoretinopathy
- Ganglion CystIwahashi isExperienced. Learn about Ganglion Cyst.
- Juvenile Idiopathic Arthritis (JIA)Iwahashi isExperienced. Learn about Juvenile Idiopathic Arthritis (JIA).
- Late-Onset Retinal DegenerationIwahashi isExperienced. Learn about Late-Onset Retinal Degeneration.